ACM Research, Inc. (ACMR) Spending and interest coverage
- R&D / revenue · 12 months: Value 15.66%; Formula and calculation Research and development expense / revenue. Period ending 2026-06-30..
- Stock-based compensation / revenue · 12 months: Value 2.52%; Formula and calculation Share-based compensation / revenue. Period ending 2026-06-30..
- Interest coverage · 12 months: Value (m); Formula and calculation Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified..
Spending and interest coverage
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| R&D / revenue · 12 months | 15.66% | Research and development expense / revenue. Period ending 2026-06-30. $162.47M ÷ $1.04B × 100 ≈ 15.66% |
| Stock-based compensation / revenue · 12 months | 2.52% | Share-based compensation / revenue. Period ending 2026-06-30. $26.19M ÷ $1.04B × 100 ≈ 2.52% |
| Interest coverage · 12 months | (m) | Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Research and development spending | 162.47M USD | Research and Development Expense |
| Revenue | 1.04B USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Stock-based compensation | 26.19M USD | Share-based Payment Arrangement, Noncash Expense |
| Operating income | 137.88M USD | Operating Income (Loss) |
| Interest expense · reported / estimated | (m) | Interest Expense · Estimated expense assumptions |
Latest interest expense basis: (m). Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Research and development spending (USD) | Revenue (USD) | Stock-based compensation (USD) | Operating income (USD) | Interest expense · reported / estimated (USD) | R&D / revenue | SBC / revenue | Interest coverage | Interest expense basis |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $162.47M | $1.04B | $26.19M | $137.88M | (m) | 15.66% | 2.52% | (m) | (m) |
| 2026-03-31 | $154.03M | $960.23M | $29.38M | $119.83M | (m) | 16.04% | 3.06% | (m) | (m) |
| 2025-12-31 | $144.99M | $901.31M | $33.58M | $109.43M | (m) | 16.09% | 3.73% | (m) | (m) |
| 2025-09-30 | $128.72M | $880.35M | $35.93M | $130.38M | (m) | 14.62% | 4.08% | (m) | (m) |
| 2025-06-30 | $116.91M | $815.17M | $40.25M | $145.64M | (m) | 14.34% | 4.94% | (m) | (m) |
| 2025-03-31 | $109.06M | $802.27M | $44.82M | $151.54M | (m) | 13.59% | 5.59% | (m) | (m) |
| 2024-12-31 | $105.47M | $782.12M | $49.58M | $151.00M | (m) | 13.49% | 6.34% | (m) | (m) |
| 2024-09-30 | $110.19M | $728.97M | $53.46M | $130.38M | (m) | 15.12% | 7.33% | (m) | (m) |
| 2024-06-30 | $108.50M | $693.56M | $52.16M | $119.37M | (m) | 15.64% | 7.52% | (m) | (m) |
| 2024-03-31 | $102.60M | $635.66M | $39.84M | $112.21M | $2.77M | 16.14% | 6.27% | 40.52× | Reported |
| 2023-12-31 | $92.71M | $557.72M | $27.34M | $95.84M | $2.68M | 16.62% | 4.90% | 35.75× | Reported |
| 2023-09-30 | $78.08M | $495.94M | $17.16M | $89.14M | $2.65M | 15.74% | 3.46% | 33.60× | Reported |
| 2023-06-30 | $67.61M | $461.08M | $8.47M | $87.60M | $2.43M | 14.66% | 1.84% | 36.02× | Reported |
| 2023-03-31 | $58.91M | $420.90M | $8.42M | $77.20M | $2.09M | 14.00% | 2.00% | 36.96× | Reported |
| 2022-12-31 | $62.23M | $388.83M | $7.73M | $59.03M | $1.66M | 16.00% | 1.99% | 35.67× | Reported |
| 2022-09-30 | $57.30M | $375.43M | $6.53M | $61.49M | $1.18M | 15.26% | 1.74% | 52.24× | Reported |
| 2022-06-30 | $49.48M | $308.74M | $5.92M | $41.65M | $949.00K | 16.03% | 1.92% | 43.89× | Reported |
| 2022-03-31 | $46.05M | $258.20M | $5.28M | $25.95M | $837.00K | 17.83% | 2.05% | 31.00× | Reported |
| 2021-12-31 | $34.21M | $259.75M | $5.12M | $38.70M | $765.00K | 13.17% | 1.97% | 50.59× | Reported |
| 2021-09-30 | $27.17M | $210.17M | $5.13M | $25.01M | $945.00K | 12.93% | 2.44% | 26.46× | Reported |
| 2021-06-30 | $23.66M | $190.82M | $6.63M | $20.72M | $1.03M | 12.40% | 3.47% | 20.19× | Reported |
| 2021-03-31 | $20.95M | $176.01M | $6.15M | $23.72M | $1.06M | 11.90% | 3.49% | 22.38× | Reported |
| 2020-12-31 | $19.12M | $156.62M | $5.63M | $21.49M | $982.00K | 12.21% | 3.59% | 21.89× | Reported |
| 2020-09-30 | $16.54M | $135.67M | $4.98M | $19.91M | $818.00K | 12.19% | 3.67% | 24.34× | Reported |
| 2020-06-30 | $15.69M | $121.43M | $3.75M | $19.43M | $751.00K | 12.92% | 3.09% | 25.88× | Reported |
| 2020-03-31 | $13.81M | $111.39M | $3.52M | $16.76M | $717.00K | 12.40% | 3.16% | 23.37× | Reported |
| 2019-12-31 | $12.90M | $107.52M | $3.57M | $17.79M | $745.00K | 12.00% | 3.32% | 23.88× | Reported |
| 2019-09-30 | $13.75M | $103.76M | $3.51M | $16.58M | $672.00K | 13.26% | 3.38% | 24.68× | Reported |
| 2019-06-30 | $12.53M | $93.52M | $2.37M | $12.96M | $579.00K | 13.39% | 2.53% | 22.38× | Reported |
| 2019-03-31 | $11.60M | $85.38M | $1.93M | $10.63M | $534.00K | 13.59% | 2.26% | 19.90× | Reported |
| 2018-12-31 | $10.38M | $74.64M | $3.36M | $6.47M | $498.00K | 13.91% | 4.51% | 12.99× | Reported |
| 2018-09-30 | $8.29M | $70.99M | $2.70M | $7.60M | $444.00K | 11.67% | 3.80% | 17.11× | Reported |
| 2018-06-30 | $7.23M | $52.70M | $2.63M | $2.88M | $365.00K | 13.72% | 5.00% | 7.90× | Reported |
| 2018-03-31 | $5.75M | $40.59M | $2.96M | $349.00K | $302.00K | 14.17% | 7.30% | 1.16× | Reported |
| 2017-12-31 | $5.14M | $36.51M | $1.62M | $700.00K | $277.00K | 14.07% | 4.44% | 2.53× | Reported |
| 2017-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-12-31 | $3.26M | $27.37M | $383.00K | $3.49M | $181.00K | 11.91% | 1.40% | 19.28× | Reported |
| 2016-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Azenta, Inc. (AZTA) | United States | $1.499B | -9.09 |
| Velo3D, Inc. (VELO) | United States | $0.354B | -10.81 |
| Energy Recovery, Inc. (ERII) | United States | $0.349B | 30.09 |
| AMTECH SYSTEMS INC (ASYS) | United States | $0.269B | 100.98 |
| SONO TEK CORP (SOTK) | United States | $0.075B | 37.58 |
| TRIO-TECH INTERNATIONAL (TRT) | United States | $0.075B | 587.94 |
| CVD EQUIPMENT CORP (CVV) | United States | $0.031B | 5.16 |
| VEECO INSTRUMENTS INC (VECO) | United States | $2.777B | 199.41 |
| AXCELIS TECHNOLOGIES INC (ACLS) | United States | $3.583B | 63.11 |
| LAM RESEARCH CORP (LRCX) | United States | $384.118B | 65.03 |